The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer<i>in vivo</i>Frank P. Vendetti, Christopher J. Bakkenist|Oncotarget|2015Cited by 240
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiationFrank P. Vendetti, Christopher J. Bakkenist|Scientific Reports|2017Cited by 20
αKG-mediated carnitine synthesis drives DNA repair via histone acetylationApoorva Uboveja, Katherine M. Aird, Aidan R. Cole et al.|Nature|2026Cited by 0